Click Here to return To Results

 

Advanced Parkinson Disease Treated with Rotigotine Transdermal System PREFER Study Neurol 68:1262-1267, LeWitt,P.A.,et al, 2007 See this aricle in Pubmed Article Abstract Transdermal rotigotine significantly improved "off" time in subjects with Parkinson disease not optimally controlled with levodopa and was safe and well tolerated, with typical dopaminergic side effects and occasional application site reactions.

Related Tags

(click to filter results - removes previous filter) dopamine agonist Parkinson disease Parkinson disease,treatment of quality of care rotigotine transdermal medication treatment of neurologic disorder

Click Here to return To Results